Menu
  • Join
  • Login
  • Contact
 

Search abstracts


OBETICHOLIC ACID: AN OPTION FOR PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: GONZALEZ SUAREZ, Silvia (HOSPITAL VIRGEN DE LA SALUD, PHARMACY, Spain)
  • Co-author(s): Silvia González Suárez: PHARMACY, HOSPITAL VIRGEN DE LA SALUD, TOLEDO, Spain
    Araceli Fernández-Corada Sánchez: PHARMACY, HOSPITAL VIRGEN DE LA SALUD, TOLEDO, Spain
    Ana Andrea García Sancristán: PHARMACY, HOSPITAL VIRGEN DE LA SALUD, TOLEDO, Spain
    Ana Domínguez Barahona: PHARMACY, HOSPITAL VIRGEN DE LA SALUD, TOLEDO, Spain
    Raúl López Álvarez: PHARMACY, HOSPITAL VIRGEN DE LA SALUD, TOLEDO, Spain
    Paloma Moya Gómez: PHARMACY, HOSPITAL VIRGEN DE LA SALUD, TOLEDO, Spain
  • Abstract:

    Background

    Obeticholic acid is an orphan drug indicated in combination with ursodeoxycholic acid(UDCA), to treat primary biliary cholangitis(PBC) in adults non-responders to UDCA or when UDCA is not well tolerated.

    Methods

    Retrospective study of patients treated between July2017 and March2019. Patients information were reviewed from electronic

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses